Author:
Parashar Deepti,Rajendran Vinoth,Shukla Ravi,Sistla Ramakrishna
Funder
Department of Science & Technology
Reference208 articles.
1. RNAi therapeutics: principles, prospects and challenges;Aagaard;Adv. Drug Deliv. Rev.,2007
2. Lung-endothelium-targeted nanoparticles based on a pH-sensitive lipid and the GALA peptide enable robust gene silencing and the regression of metastatic lung cancer;Abd Elwakil;Adv. Funct. Mater.,2019
3. Pharmacological characterization of chemically synthesized monomeric phi29 pRNA nanoparticles for systemic delivery;Abdelmawla;Mol. Ther.,2011
4. Evaluation of efficacy, biodistribution, and inflammation for a potent siRNA nanoparticle: effect of dexamethasone co-treatment;Abrams;Mol. Ther.,2010
5. Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis;Adams;N. Engl. J. Med.,2018
Cited by
36 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献